Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

David Hillus, Tatjana Schwarz, Pinkus Tober‐Lau, Kanika Vanshylla, Hana Hastor, Charlotte Thibeault, Stefanie Jentzsch, Elisa T. Helbig, Lena J. Lippert, Patricia Tscheak, Marie Luisa Schmidt, Johanna Riege, André Solarek, Christof von Kalle, Chantip Dang‐Heine, Henning Gruell, Piotr Kopankiewicz, Norbert Suttorp, Christian Drosten, Harald Bias, Joachim Seybold, Ben Al-Rim, Lara Bardtke, Jörn Beheim-Schwarzbach, Kerstin Behn, Léon Bergfeld, Norma Bethke, Tobias Bleicker, Dana Briesemeister, Sophia Brumhard, Claudia Conrad, Sebastian Dieckmann, Doris Frey, Julie-Anne Gabelich, Philipp Georg, U. Glaser, Lisbeth Hasler, Andreas Hetey, Anna Hiller, Alexandra Horn, Claudia Hülso, Luisa Kegel, Willi Koch, Alexander Krannich, Paolo Kroneberg, Michelle Lisy, Petra Mackeldanz, Birgit Maeß, Friederike Münn, Nadine Olk, Christian Peiser, Kai Pohl, A. Hermel, Maria Rönnefarth, Carolin Rubisch, Angela Sanchez Rezza, Isabelle Schellenberger, Viktoria Schenkel, Jenny Schlesinger, Sein Schmidt, Georg Schwanitz, Anne-Sophie Sinnigen, Paula Stubbemann, Julia Tesch, Denise Treue, Daniel Wendisch, Saskia Zvorc, Florian Klein, Florian Kurth, Victor M. Corman, Leif Erik Sander